Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
2018 · Genome Medicine · 168 citations
https://doi.org/10.1186/s13073-018-0605-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
505
Citations
8
h-index
7
i10-index
Shirley Mo is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Acute Myeloid Leukemia Research & Bariatric Surgery and Outcomes. The author has an h-index of 8, co-authored 18 publications.
ORCID: 0000-0002-7830-0340https://doi.org/10.1186/s13073-018-0605-7
https://doi.org/10.1007/s00423-023-02805-8
https://doi.org/10.1182/bloodadvances.2024014460
Click to start Chat